News
B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...
Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular ...
Leading generic drugmakers have mixed views on President Donald Trump’s repeated threats to impose tariffs on pharmaceutical goods in a bid to push global pharma majors to shift their manufacturing ...
NEW YORK — (AP) — U.S. stock indexes are drifting lower on Tuesday, while oil prices rise again.
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
Shares of home energy technology company Enphase (NASDAQ:ENPH) fell 27.5% in the morning session after a U.S. Senate panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results